The ongoing revolution in genomic science is having an impact on many facets of modern life, including toxic tort litigation. This point was apparent at the recently held American Conference Institute’s 23rd National Forum on Asbestos Claims & Litigation (May 21-23, 2018) in Chicago, where we presented in a session titled “The Meso Gene.” In our presentations, we covered various topics related to waging a genomics defense in toxic tort cases, including the following:

• Expanding the scientific limits of epidemiology as applied to specific causation in asbestos and talc cases
• Recent legal motions requiring plaintiffs to test for certain genes including BAP1
• Identifying newer genes and related scientific studies
• Determining whether there is a “meso gene” that makes plaintiffs predisposed or susceptible to certain types of cancer

You can download a copy of our slides below.

Also, don’t forget to check out our recent blog post on recognizing legal cases where a genetic defense will be most beneficial.

Download a complimentary copy of the two presentations titled: Evaluating Predispositions to Certain Types of Cancer and Update on Genomics in Mesothelioma Litigation.